To include your compound in the COVID-19 Resource Center, submit it here.
On Monday, Allergan plc (NYSE:AGN) sank $7.11 to $198.41 after a federal judge invalidated four patents covering its dry-eye drug Restasis cyclosporine. Although the court found that
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury